Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization

NCT00317252 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Kidney Failure

Interventions

DRUG: Hold ACEI or ARB

Sponsor

Hamilton Health Sciences Corporation